15 Pharmaceutical Executive Search Firms and Recruiters Compared

GeneCoda's Deal Sheet, which it describes as a sampling of searches over 20+ years, lists 30 searches for pharmaceutical companies by title and therapeutic area, among them a chief medical officer, vice presidents of regulatory affairs and of research and development, and an executive vice president of clinical operations. It does not name the employers. On its testimonials page (opens in a new tab), first published in 2018, Jeff Wolf, founder and CEO of Heat Biologics, calls Don Alexander of GeneCoda "our go-to guy when we need to bring in new senior management".

The firm describes itself as a boutique retained search firm working only in life sciences, from VP to C-suite. Its pharmaceutical search page (opens in a new tab) covers research, clinical, regulatory, CMC and technical operations, market access, commercial, finance and business development leaders. Its client FAQ (opens in a new tab) explains the flat fee as a way to avoid the conflicts of percentage-based fees.

Klein Hersh's homepage lists recent placements with dates: a chief financial officer at Achieve Life Sciences (October 2, 2026), a chief business officer at GlycoEra AG (September 16, 2026) and a chief financial officer at Sparrow Pharmaceuticals (September 9, 2026). Its March 2026 case study describes Project Farma, an engineering services provider to biotech and pharma companies, which had hired its chief operating officer through Klein Hersh in April 2025 and returned with a goal of ten senior hires in two quarters. Seven senior executives had been placed, with three searches under way, when the case was published.

The pharma and biotech practice page (opens in a new tab) lists the roles it recruits in four areas: executive leadership (CEO to chief regulatory officer), clinical, discovery and preclinical, and commercialization, including heads of market access and pricing. It also offers interim executives. Paul Sekhri of vTv Therapeutics says working with the firm "is like working with an internal team". The pages read do not state its fees or search model.

Alpha Apex Group's biopharma page offers executive search for leaders and specialist recruitment in biotech and clinical research. It describes market and talent mapping at the start, a recruitment strategy for each client that runs through offer negotiation, and support for onboarding and integration after the placement.

The page names no pharma-specific executive titles, biopharma placements, fees or timelines, so ask for biopharma references and agree the role, search model and terms directly.

Boards and leadership teams for biopharma companies are the focus of Heidrick's Biopharmaceuticals page, part of its Healthcare & Life Sciences practice. It says the firm helps build them, and lists related advisory work from talent assessment to CEO onboarding and team acceleration.

The pages read name no biopharma search, client or term.

Korn Ferry's pharma search work appears on the profile of Dr. Jasmine Ferrer, its Managing Partner for Biotechnology, based in Philadelphia. Her profile says she recruits CEOs, heads of R&D, chief medical officers, chief financial officers and chief business officers for venture-backed and emerging biotechnology and pharmaceutical companies, and that she worked in business development at Amgen and Pfizer.

The firm's life sciences consulting page (opens in a new tab) describes talent strategy, assessment, succession and leadership development for biotech and pharma companies. Neither page names a client or placement.

Lock's pharma page carries testimonials from named leaders at pharmaceutical companies. Scott Lambert, senior national sales director at Eisai Canada, mentions "the quality of candidates they have placed within our organization". John McKendry, president and CEO of Kye Pharmaceuticals, says he has recommended the firm many times over the 20+ years he has worked with it, and Marc Leger, chief commercial officer of Valeo Pharma, describes "several mandates across the country". Ferring Pharmaceuticals' president is also quoted. The testimonials carry no dates of their own, on a page first published in 2021.

The practice recruits from entry level to C-suite, including chief medical officers, and names roles such as director of pharmacovigilance, medical affairs director and regulatory affairs manager. The page says the firm has worked with large pharma companies and startups, particularly around Montreal, Toronto and Boston.

A global pharmaceutical company with revenues of over $45 billion is the subject of one of Russell Reynolds' published cases: since 2018 the firm has placed 20 leaders there in legal, corporate affairs, public policy and communications roles, plus three at the consumer health business it spun out. Its technology leader search page (opens in a new tab) describes appointing a chief AI and analytics officer for a global biopharmaceutical company after an oncology acquisition. Both clients are unnamed.

The Pharmaceuticals and Biotechnology practice works with boards, CEOs and senior executives across global pharma and emerging biotech. Its legal and technology search pages each say such a search typically takes 14 to 25 weeks from initiation to offer acceptance. The pages read state no fees.

Spencer Stuart's Biopharma practice reports more than 700 executive and board assignments for biotechnology and pharmaceutical companies over a three-year period, from startups to major companies. The page names no client or search.

It lists functional expertise in research and development, manufacturing and quality, managed markets and reimbursement, and human resources, alongside board and leadership advisory work.

Permanent, temporary and executive recruitment for pharma clients were the three services on Hays' US pharmaceuticals page read in October 2026, with specialist teams for scientists, clinical operations and development, biometrics, regulatory affairs, quality and drug safety, and medical affairs and commercial roles. Its executive search page, read at the same time, described decades of retained search experience without mentioning pharma.

Neither page, as read, names a pharma client or placement, and the US case studies page read on October 6, 2026 shows no pharma example.

On its pharma page, Healthcare Recruiters International (HCRI) lists recent pharma searches by title, among them a chief medical officer, VP of clinical research, VP of business development, VP of sales, medical director and clinical supply director, without naming employers. Its pages report 1,000+ completed C-level search engagements, without saying how many were for pharma companies.

HCRI has recruited only in healthcare and life sciences since 1984. Its process page (opens in a new tab) sets a goal of completing all engagements in six weeks, without saying whether that ends at a shortlist or a hire, and says placed candidates typically earn $50,000 to $300,000 a year.

PLR's Anti-Fee Model page (opens in a new tab) gives four worked examples. A global program clinical head for a global pharmaceutical company, on a $265,000 base salary, took 65 days to fill and cost $31,020. A site quality head on a $235,000 base took 68 days and cost $24,447. The page describes the clients by type only.

Clients pay by the hour for the time a search takes, keep the resumes and references the search generates, and pay nothing extra for several hires from one search. PLR guarantees a placement at under a 25% fee, or it works for free until the role is filled, and says it aims the model at companies with more than 500 employees. PLR is part of Stone Harbor Staffing Group; the PharmaLogics Recruiting address redirects to its page. Its pages do not describe the service as executive search.

Real, part of the SThree group, reports placing 2,518 specialists in 2024 across its 16 offices, a firm-wide figure that does not separate pharma or leadership hires. Its UK pharmaceutical page offers executive search for "high-impact leadership roles", sourcing leaders for pharmaceutical companies from associate directors to regulatory experts, alongside permanent and contract recruitment in regulatory affairs, clinical trials and drug safety.

Its Chicago pharmaceutical page (opens in a new tab) lists executive leaders among the hires it handles. Neither page names a pharma client or leadership placement, and neither states fees or timelines. The US pharma and biotech page concentrates on scientific and medical affairs staffing, so confirm which office would run a leadership search.

Scientific Search publishes the most detailed replacement terms of the firms here on its policies and guarantees page (opens in a new tab). If a direct hire resigns without just cause or is dismissed for cause within 90 days, it replaces the person at no cost; between days 91 and 365 a replacement costs a pro-rated share of the original fee (5/12ths in the fifth month), and the guarantee lapses if the fee is not paid within 10 days. It does not apply if the role's duties change substantially or the person leaves in a general downsizing. The percentage itself is not stated.

The pharma page covers technical, management and executive levels, including CXO, president, VP and director roles, and the firm also offers retained search. Its testimonials include directors at pharmaceutical and biotech manufacturers describing technical hires, such as contract process engineers; none identifies an executive placement. The firm began in 1983.

Fourteen recent placements appear on Smith Hanley's pharma page by role and company type, including a chief business officer at a clinical-stage biotech, a VP of medical affairs at a mid-size pharma company and an executive director of enterprise data analytics and AI. Employers are not named, and the placements are undated on a page last updated in June 2026.

The firm says it places pharma and biotech staff from senior leaders to individual contributors, across discovery, clinical, regulatory, medical affairs, commercial and market research. Its two named pharma recruiters work in commercial analytics and market research. Its unnamed testimonials include a senior director of commercial analytics at a mid-size pharma company.

Senior leaders across life sciences, including pharmaceuticals, are the remit of SRG's Executive and Technical Search service, from permanent leaders to interim consultants. Its FAQ names roles such as chief scientific officer, R&D director and regulatory affairs leader, and says a life sciences executive search typically takes four to eight weeks, depending on seniority and market conditions, without saying whether that ends at a shortlist, an offer or a start date. Its pharmaceutical page (opens in a new tab) mentions recruitment teams in the UK and the US.

The pages read name no executive client or placement. The pharma case study shown on its case-study page describes an insourced flexible staffing model for a global pharmaceutical company's manufacturing operation; it does not describe an executive search.